Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example
Crossref DOI link: https://doi.org/10.1136/rmdopen-2015-000154
Published Online: 2016-02-07
Published Print: 2016-02
Update policy: https://doi.org/10.1136/crossmarkpolicy
Lai, Zhihong
La Noce, Anna